nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomifene—CYP1A2—Sorafenib—thyroid cancer	0.0574	0.243	CbGbCtD
Clomifene—ABCB1—Sorafenib—thyroid cancer	0.0502	0.213	CbGbCtD
Clomifene—CYP3A4—Vandetanib—thyroid cancer	0.0499	0.211	CbGbCtD
Clomifene—ABCB1—Doxorubicin—thyroid cancer	0.0305	0.129	CbGbCtD
Clomifene—CYP3A4—Sorafenib—thyroid cancer	0.0301	0.127	CbGbCtD
Clomifene—Hepatocellular carcinoma—Sorafenib—thyroid cancer	0.0288	0.0503	CcSEcCtD
Clomifene—Hepatic cancer—Sorafenib—thyroid cancer	0.0262	0.0458	CcSEcCtD
Clomifene—Photopsia—Vandetanib—thyroid cancer	0.0245	0.0428	CcSEcCtD
Clomifene—Heart malformation—Epirubicin—thyroid cancer	0.0206	0.036	CcSEcCtD
Clomifene—Heart malformation—Doxorubicin—thyroid cancer	0.019	0.0333	CcSEcCtD
Clomifene—CYP3A4—Doxorubicin—thyroid cancer	0.0183	0.0773	CbGbCtD
Clomifene—Heart disease congenital—Epirubicin—thyroid cancer	0.0168	0.0294	CcSEcCtD
Clomifene—Heart disease congenital—Doxorubicin—thyroid cancer	0.0156	0.0272	CcSEcCtD
Clomifene—Visual acuity reduced—Vandetanib—thyroid cancer	0.0131	0.0229	CcSEcCtD
Clomifene—Cyst—Vandetanib—thyroid cancer	0.0116	0.0204	CcSEcCtD
Clomifene—Ascites—Sorafenib—thyroid cancer	0.0116	0.0202	CcSEcCtD
Clomifene—Acne—Vandetanib—thyroid cancer	0.00925	0.0162	CcSEcCtD
Clomifene—Embolism—Sorafenib—thyroid cancer	0.00818	0.0143	CcSEcCtD
Clomifene—Cataract—Vandetanib—thyroid cancer	0.00818	0.0143	CcSEcCtD
Clomifene—Leukaemia—Epirubicin—thyroid cancer	0.00721	0.0126	CcSEcCtD
Clomifene—Neoplasm—Vandetanib—thyroid cancer	0.00704	0.0123	CcSEcCtD
Clomifene—Leukaemia—Doxorubicin—thyroid cancer	0.00667	0.0117	CcSEcCtD
Clomifene—Pancreatitis—Vandetanib—thyroid cancer	0.00479	0.00837	CcSEcCtD
Clomifene—Neoplasm—Sorafenib—thyroid cancer	0.00475	0.0083	CcSEcCtD
Clomifene—Pollakiuria—Vandetanib—thyroid cancer	0.00451	0.00789	CcSEcCtD
Clomifene—Erythema nodosum—Epirubicin—thyroid cancer	0.00449	0.00785	CcSEcCtD
Clomifene—Renal failure—Vandetanib—thyroid cancer	0.00428	0.00749	CcSEcCtD
Clomifene—Ascites—Epirubicin—thyroid cancer	0.00427	0.00747	CcSEcCtD
Clomifene—Erythema nodosum—Doxorubicin—thyroid cancer	0.00415	0.00726	CcSEcCtD
Clomifene—Ascites—Doxorubicin—thyroid cancer	0.00395	0.00691	CcSEcCtD
Clomifene—Visual impairment—Vandetanib—thyroid cancer	0.00377	0.00659	CcSEcCtD
Clomifene—Erythema multiforme—Vandetanib—thyroid cancer	0.0037	0.00646	CcSEcCtD
Clomifene—Mood swings—Sorafenib—thyroid cancer	0.00361	0.00631	CcSEcCtD
Clomifene—Blindness—Epirubicin—thyroid cancer	0.00351	0.00613	CcSEcCtD
Clomifene—Arrhythmia—Vandetanib—thyroid cancer	0.00349	0.00611	CcSEcCtD
Clomifene—Alopecia—Vandetanib—thyroid cancer	0.00345	0.00604	CcSEcCtD
Clomifene—Blindness—Doxorubicin—thyroid cancer	0.00324	0.00567	CcSEcCtD
Clomifene—Pancreatitis—Sorafenib—thyroid cancer	0.00323	0.00565	CcSEcCtD
Clomifene—Vision blurred—Vandetanib—thyroid cancer	0.00321	0.00561	CcSEcCtD
Clomifene—Transaminases increased—Epirubicin—thyroid cancer	0.00319	0.00558	CcSEcCtD
Clomifene—Abdominal discomfort—Sorafenib—thyroid cancer	0.00316	0.00552	CcSEcCtD
Clomifene—Optic neuritis—Epirubicin—thyroid cancer	0.00316	0.00552	CcSEcCtD
Clomifene—Embolism—Epirubicin—thyroid cancer	0.00302	0.00529	CcSEcCtD
Clomifene—Loss of consciousness—Vandetanib—thyroid cancer	0.00299	0.00523	CcSEcCtD
Clomifene—Transaminases increased—Doxorubicin—thyroid cancer	0.00295	0.00516	CcSEcCtD
Clomifene—Convulsion—Vandetanib—thyroid cancer	0.00295	0.00516	CcSEcCtD
Clomifene—Hypertension—Vandetanib—thyroid cancer	0.00294	0.00514	CcSEcCtD
Clomifene—Optic neuritis—Doxorubicin—thyroid cancer	0.00292	0.0051	CcSEcCtD
Clomifene—Cyst—Epirubicin—thyroid cancer	0.0029	0.00508	CcSEcCtD
Clomifene—Arthralgia—Vandetanib—thyroid cancer	0.0029	0.00507	CcSEcCtD
Clomifene—Chest pain—Vandetanib—thyroid cancer	0.0029	0.00507	CcSEcCtD
Clomifene—Renal failure—Sorafenib—thyroid cancer	0.00289	0.00505	CcSEcCtD
Clomifene—Anxiety—Vandetanib—thyroid cancer	0.00289	0.00505	CcSEcCtD
Clomifene—Jaundice—Sorafenib—thyroid cancer	0.00286	0.00501	CcSEcCtD
Clomifene—Embolism—Doxorubicin—thyroid cancer	0.0028	0.00489	CcSEcCtD
Clomifene—Oedema—Vandetanib—thyroid cancer	0.00278	0.00486	CcSEcCtD
Clomifene—Thrombosis—Epirubicin—thyroid cancer	0.00274	0.00479	CcSEcCtD
Clomifene—Cyst—Doxorubicin—thyroid cancer	0.00269	0.0047	CcSEcCtD
Clomifene—Dermatitis atopic—Epirubicin—thyroid cancer	0.00262	0.00458	CcSEcCtD
Clomifene—Scotoma—Epirubicin—thyroid cancer	0.00256	0.00447	CcSEcCtD
Clomifene—Thrombosis—Doxorubicin—thyroid cancer	0.00254	0.00444	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00253	0.00442	CcSEcCtD
Clomifene—Insomnia—Vandetanib—thyroid cancer	0.00251	0.00439	CcSEcCtD
Clomifene—Paraesthesia—Vandetanib—thyroid cancer	0.00249	0.00436	CcSEcCtD
Clomifene—Erythema multiforme—Sorafenib—thyroid cancer	0.00249	0.00436	CcSEcCtD
Clomifene—Dyspnoea—Vandetanib—thyroid cancer	0.00248	0.00433	CcSEcCtD
Clomifene—Tinnitus—Sorafenib—thyroid cancer	0.00246	0.0043	CcSEcCtD
Clomifene—Flushing—Sorafenib—thyroid cancer	0.00245	0.00428	CcSEcCtD
Clomifene—Dermatitis atopic—Doxorubicin—thyroid cancer	0.00243	0.00424	CcSEcCtD
Clomifene—Fatigue—Vandetanib—thyroid cancer	0.00239	0.00419	CcSEcCtD
Clomifene—Constipation—Vandetanib—thyroid cancer	0.00238	0.00415	CcSEcCtD
Clomifene—Pain—Vandetanib—thyroid cancer	0.00238	0.00415	CcSEcCtD
Clomifene—Scotoma—Doxorubicin—thyroid cancer	0.00236	0.00413	CcSEcCtD
Clomifene—Arrhythmia—Sorafenib—thyroid cancer	0.00236	0.00412	CcSEcCtD
Clomifene—Alopecia—Sorafenib—thyroid cancer	0.00233	0.00407	CcSEcCtD
Clomifene—Erythema—Sorafenib—thyroid cancer	0.0023	0.00401	CcSEcCtD
Clomifene—Body temperature increased—Vandetanib—thyroid cancer	0.0022	0.00384	CcSEcCtD
Clomifene—Syncope—Sorafenib—thyroid cancer	0.00206	0.0036	CcSEcCtD
Clomifene—Loss of consciousness—Sorafenib—thyroid cancer	0.00202	0.00353	CcSEcCtD
Clomifene—Asthenia—Vandetanib—thyroid cancer	0.00199	0.00348	CcSEcCtD
Clomifene—Hypertension—Sorafenib—thyroid cancer	0.00198	0.00347	CcSEcCtD
Clomifene—Pruritus—Vandetanib—thyroid cancer	0.00197	0.00344	CcSEcCtD
Clomifene—Arthralgia—Sorafenib—thyroid cancer	0.00195	0.00342	CcSEcCtD
Clomifene—Myalgia—Sorafenib—thyroid cancer	0.00195	0.00342	CcSEcCtD
Clomifene—Pulmonary embolism—Epirubicin—thyroid cancer	0.00194	0.00339	CcSEcCtD
Clomifene—Hepatocellular injury—Epirubicin—thyroid cancer	0.00194	0.00339	CcSEcCtD
Clomifene—Diarrhoea—Vandetanib—thyroid cancer	0.0019	0.00332	CcSEcCtD
Clomifene—Shock—Sorafenib—thyroid cancer	0.00184	0.00322	CcSEcCtD
Clomifene—Dizziness—Vandetanib—thyroid cancer	0.00184	0.00321	CcSEcCtD
Clomifene—Pulmonary embolism—Doxorubicin—thyroid cancer	0.0018	0.00314	CcSEcCtD
Clomifene—Hepatocellular injury—Doxorubicin—thyroid cancer	0.0018	0.00314	CcSEcCtD
Clomifene—Vomiting—Vandetanib—thyroid cancer	0.00177	0.00309	CcSEcCtD
Clomifene—Neoplasm—Epirubicin—thyroid cancer	0.00175	0.00307	CcSEcCtD
Clomifene—Rash—Vandetanib—thyroid cancer	0.00175	0.00306	CcSEcCtD
Clomifene—Dermatitis—Vandetanib—thyroid cancer	0.00175	0.00306	CcSEcCtD
Clomifene—Headache—Vandetanib—thyroid cancer	0.00174	0.00304	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00171	0.00298	CcSEcCtD
Clomifene—Mental disability—Epirubicin—thyroid cancer	0.00168	0.00294	CcSEcCtD
Clomifene—Dyspnoea—Sorafenib—thyroid cancer	0.00167	0.00292	CcSEcCtD
Clomifene—Nausea—Vandetanib—thyroid cancer	0.00165	0.00288	CcSEcCtD
Clomifene—Phlebitis—Epirubicin—thyroid cancer	0.00164	0.00286	CcSEcCtD
Clomifene—Thrombophlebitis—Epirubicin—thyroid cancer	0.00163	0.00285	CcSEcCtD
Clomifene—Neoplasm—Doxorubicin—thyroid cancer	0.00162	0.00284	CcSEcCtD
Clomifene—Fatigue—Sorafenib—thyroid cancer	0.00162	0.00282	CcSEcCtD
Clomifene—Pain—Sorafenib—thyroid cancer	0.0016	0.0028	CcSEcCtD
Clomifene—Constipation—Sorafenib—thyroid cancer	0.0016	0.0028	CcSEcCtD
Clomifene—Eye pain—Epirubicin—thyroid cancer	0.00156	0.00273	CcSEcCtD
Clomifene—Mental disability—Doxorubicin—thyroid cancer	0.00156	0.00272	CcSEcCtD
Clomifene—Phlebitis—Doxorubicin—thyroid cancer	0.00151	0.00265	CcSEcCtD
Clomifene—Hot flush—Epirubicin—thyroid cancer	0.00151	0.00263	CcSEcCtD
Clomifene—Thrombophlebitis—Doxorubicin—thyroid cancer	0.00151	0.00263	CcSEcCtD
Clomifene—Increased appetite—Epirubicin—thyroid cancer	0.0015	0.00262	CcSEcCtD
Clomifene—Menopausal symptoms—Epirubicin—thyroid cancer	0.00149	0.00261	CcSEcCtD
Clomifene—Urticaria—Sorafenib—thyroid cancer	0.00149	0.0026	CcSEcCtD
Clomifene—Body temperature increased—Sorafenib—thyroid cancer	0.00148	0.00259	CcSEcCtD
Clomifene—Eye pain—Doxorubicin—thyroid cancer	0.00144	0.00252	CcSEcCtD
Clomifene—Cerebrovascular accident—Epirubicin—thyroid cancer	0.00144	0.00251	CcSEcCtD
Clomifene—Diplopia—Epirubicin—thyroid cancer	0.00141	0.00246	CcSEcCtD
Clomifene—Hot flush—Doxorubicin—thyroid cancer	0.00139	0.00244	CcSEcCtD
Clomifene—Increased appetite—Doxorubicin—thyroid cancer	0.00139	0.00243	CcSEcCtD
Clomifene—Affect lability—Epirubicin—thyroid cancer	0.00139	0.00242	CcSEcCtD
Clomifene—Migraine—Epirubicin—thyroid cancer	0.00139	0.00242	CcSEcCtD
Clomifene—Menopausal symptoms—Doxorubicin—thyroid cancer	0.00138	0.00242	CcSEcCtD
Clomifene—Hypersensitivity—Sorafenib—thyroid cancer	0.00138	0.00241	CcSEcCtD
Clomifene—Asthenia—Sorafenib—thyroid cancer	0.00134	0.00235	CcSEcCtD
Clomifene—Mood swings—Epirubicin—thyroid cancer	0.00133	0.00233	CcSEcCtD
Clomifene—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.00133	0.00233	CcSEcCtD
Clomifene—Pruritus—Sorafenib—thyroid cancer	0.00133	0.00232	CcSEcCtD
Clomifene—Diplopia—Doxorubicin—thyroid cancer	0.0013	0.00228	CcSEcCtD
Clomifene—Migraine—Doxorubicin—thyroid cancer	0.00128	0.00224	CcSEcCtD
Clomifene—Affect lability—Doxorubicin—thyroid cancer	0.00128	0.00224	CcSEcCtD
Clomifene—Diarrhoea—Sorafenib—thyroid cancer	0.00128	0.00224	CcSEcCtD
Clomifene—Dizziness—Sorafenib—thyroid cancer	0.00124	0.00217	CcSEcCtD
Clomifene—Mood swings—Doxorubicin—thyroid cancer	0.00123	0.00216	CcSEcCtD
Clomifene—Abdominal distension—Epirubicin—thyroid cancer	0.00123	0.00214	CcSEcCtD
Clomifene—Pancreatitis—Epirubicin—thyroid cancer	0.00119	0.00209	CcSEcCtD
Clomifene—Vomiting—Sorafenib—thyroid cancer	0.00119	0.00208	CcSEcCtD
Clomifene—Rash—Sorafenib—thyroid cancer	0.00118	0.00207	CcSEcCtD
Clomifene—Dermatitis—Sorafenib—thyroid cancer	0.00118	0.00206	CcSEcCtD
Clomifene—Headache—Sorafenib—thyroid cancer	0.00117	0.00205	CcSEcCtD
Clomifene—Abdominal distension—Doxorubicin—thyroid cancer	0.00113	0.00198	CcSEcCtD
Clomifene—Pollakiuria—Epirubicin—thyroid cancer	0.00112	0.00197	CcSEcCtD
Clomifene—Nausea—Sorafenib—thyroid cancer	0.00111	0.00195	CcSEcCtD
Clomifene—Weight increased—Epirubicin—thyroid cancer	0.00111	0.00194	CcSEcCtD
Clomifene—Pancreatitis—Doxorubicin—thyroid cancer	0.0011	0.00193	CcSEcCtD
Clomifene—Renal failure—Epirubicin—thyroid cancer	0.00107	0.00187	CcSEcCtD
Clomifene—Jaundice—Epirubicin—thyroid cancer	0.00106	0.00185	CcSEcCtD
Clomifene—Pollakiuria—Doxorubicin—thyroid cancer	0.00104	0.00182	CcSEcCtD
Clomifene—Weight increased—Doxorubicin—thyroid cancer	0.00103	0.00179	CcSEcCtD
Clomifene—Renal failure—Doxorubicin—thyroid cancer	0.000987	0.00173	CcSEcCtD
Clomifene—Jaundice—Doxorubicin—thyroid cancer	0.000979	0.00171	CcSEcCtD
Clomifene—Hepatitis—Epirubicin—thyroid cancer	0.000975	0.0017	CcSEcCtD
Clomifene—Visual impairment—Epirubicin—thyroid cancer	0.000939	0.00164	CcSEcCtD
Clomifene—Erythema multiforme—Epirubicin—thyroid cancer	0.000922	0.00161	CcSEcCtD
Clomifene—Tinnitus—Epirubicin—thyroid cancer	0.000909	0.00159	CcSEcCtD
Clomifene—Flushing—Epirubicin—thyroid cancer	0.000905	0.00158	CcSEcCtD
Clomifene—Hepatitis—Doxorubicin—thyroid cancer	0.000902	0.00158	CcSEcCtD
Clomifene—Arrhythmia—Epirubicin—thyroid cancer	0.000871	0.00152	CcSEcCtD
Clomifene—Visual impairment—Doxorubicin—thyroid cancer	0.000869	0.00152	CcSEcCtD
Clomifene—Alopecia—Epirubicin—thyroid cancer	0.000861	0.00151	CcSEcCtD
Clomifene—Erythema multiforme—Doxorubicin—thyroid cancer	0.000853	0.00149	CcSEcCtD
Clomifene—Erythema—Epirubicin—thyroid cancer	0.000848	0.00148	CcSEcCtD
Clomifene—Tinnitus—Doxorubicin—thyroid cancer	0.000841	0.00147	CcSEcCtD
Clomifene—Flushing—Doxorubicin—thyroid cancer	0.000837	0.00146	CcSEcCtD
Clomifene—Flatulence—Epirubicin—thyroid cancer	0.000836	0.00146	CcSEcCtD
Clomifene—Tension—Epirubicin—thyroid cancer	0.000833	0.00146	CcSEcCtD
Clomifene—Nervousness—Epirubicin—thyroid cancer	0.000824	0.00144	CcSEcCtD
Clomifene—Back pain—Epirubicin—thyroid cancer	0.000821	0.00143	CcSEcCtD
Clomifene—Arrhythmia—Doxorubicin—thyroid cancer	0.000806	0.00141	CcSEcCtD
Clomifene—Vision blurred—Epirubicin—thyroid cancer	0.0008	0.0014	CcSEcCtD
Clomifene—Alopecia—Doxorubicin—thyroid cancer	0.000797	0.00139	CcSEcCtD
Clomifene—Erythema—Doxorubicin—thyroid cancer	0.000785	0.00137	CcSEcCtD
Clomifene—Flatulence—Doxorubicin—thyroid cancer	0.000774	0.00135	CcSEcCtD
Clomifene—Tension—Doxorubicin—thyroid cancer	0.00077	0.00135	CcSEcCtD
Clomifene—Nervousness—Doxorubicin—thyroid cancer	0.000762	0.00133	CcSEcCtD
Clomifene—Vertigo—Epirubicin—thyroid cancer	0.000762	0.00133	CcSEcCtD
Clomifene—Syncope—Epirubicin—thyroid cancer	0.000761	0.00133	CcSEcCtD
Clomifene—Back pain—Doxorubicin—thyroid cancer	0.000759	0.00133	CcSEcCtD
Clomifene—Palpitations—Epirubicin—thyroid cancer	0.00075	0.00131	CcSEcCtD
Clomifene—Loss of consciousness—Epirubicin—thyroid cancer	0.000746	0.0013	CcSEcCtD
Clomifene—Vision blurred—Doxorubicin—thyroid cancer	0.00074	0.00129	CcSEcCtD
Clomifene—Convulsion—Epirubicin—thyroid cancer	0.000735	0.00129	CcSEcCtD
Clomifene—Hypertension—Epirubicin—thyroid cancer	0.000733	0.00128	CcSEcCtD
Clomifene—Myalgia—Epirubicin—thyroid cancer	0.000722	0.00126	CcSEcCtD
Clomifene—Arthralgia—Epirubicin—thyroid cancer	0.000722	0.00126	CcSEcCtD
Clomifene—Chest pain—Epirubicin—thyroid cancer	0.000722	0.00126	CcSEcCtD
Clomifene—Anxiety—Epirubicin—thyroid cancer	0.00072	0.00126	CcSEcCtD
Clomifene—Vertigo—Doxorubicin—thyroid cancer	0.000705	0.00123	CcSEcCtD
Clomifene—Syncope—Doxorubicin—thyroid cancer	0.000704	0.00123	CcSEcCtD
Clomifene—Palpitations—Doxorubicin—thyroid cancer	0.000694	0.00121	CcSEcCtD
Clomifene—Oedema—Epirubicin—thyroid cancer	0.000692	0.00121	CcSEcCtD
Clomifene—Loss of consciousness—Doxorubicin—thyroid cancer	0.00069	0.00121	CcSEcCtD
Clomifene—Shock—Epirubicin—thyroid cancer	0.000681	0.00119	CcSEcCtD
Clomifene—Convulsion—Doxorubicin—thyroid cancer	0.00068	0.00119	CcSEcCtD
Clomifene—Hypertension—Doxorubicin—thyroid cancer	0.000678	0.00119	CcSEcCtD
Clomifene—Tachycardia—Epirubicin—thyroid cancer	0.000676	0.00118	CcSEcCtD
Clomifene—Chest pain—Doxorubicin—thyroid cancer	0.000668	0.00117	CcSEcCtD
Clomifene—Myalgia—Doxorubicin—thyroid cancer	0.000668	0.00117	CcSEcCtD
Clomifene—Arthralgia—Doxorubicin—thyroid cancer	0.000668	0.00117	CcSEcCtD
Clomifene—Anxiety—Doxorubicin—thyroid cancer	0.000666	0.00116	CcSEcCtD
Clomifene—Oedema—Doxorubicin—thyroid cancer	0.000641	0.00112	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000631	0.0011	CcSEcCtD
Clomifene—Shock—Doxorubicin—thyroid cancer	0.00063	0.0011	CcSEcCtD
Clomifene—CYP19A1—Biological oxidations—RXRA—thyroid cancer	0.000627	0.00327	CbGpPWpGaD
Clomifene—Insomnia—Epirubicin—thyroid cancer	0.000626	0.0011	CcSEcCtD
Clomifene—Tachycardia—Doxorubicin—thyroid cancer	0.000625	0.00109	CcSEcCtD
Clomifene—ESR1—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	0.000624	0.00325	CbGpPWpGaD
Clomifene—Paraesthesia—Epirubicin—thyroid cancer	0.000622	0.00109	CcSEcCtD
Clomifene—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	0.00062	0.00323	CbGpPWpGaD
Clomifene—Dyspnoea—Epirubicin—thyroid cancer	0.000617	0.00108	CcSEcCtD
Clomifene—ESR1—Generic Transcription Pathway—THRB—thyroid cancer	0.000604	0.00315	CbGpPWpGaD
Clomifene—Fatigue—Epirubicin—thyroid cancer	0.000597	0.00104	CcSEcCtD
Clomifene—EBP—Metabolism—TPR—thyroid cancer	0.000595	0.0031	CbGpPWpGaD
Clomifene—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—thyroid cancer	0.000594	0.00309	CbGpPWpGaD
Clomifene—ESR1—ATF-2 transcription factor network—CCND1—thyroid cancer	0.000593	0.00309	CbGpPWpGaD
Clomifene—Pain—Epirubicin—thyroid cancer	0.000592	0.00104	CcSEcCtD
Clomifene—Constipation—Epirubicin—thyroid cancer	0.000592	0.00104	CcSEcCtD
Clomifene—CYP11A1—Metabolism—NDUFA13—thyroid cancer	0.000592	0.00308	CbGpPWpGaD
Clomifene—ESR1—Plasma membrane estrogen receptor signaling—KRAS—thyroid cancer	0.000588	0.00307	CbGpPWpGaD
Clomifene—EBP—Metabolism—PRKAR1A—thyroid cancer	0.000586	0.00305	CbGpPWpGaD
Clomifene—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000584	0.00102	CcSEcCtD
Clomifene—Insomnia—Doxorubicin—thyroid cancer	0.000579	0.00101	CcSEcCtD
Clomifene—Paraesthesia—Doxorubicin—thyroid cancer	0.000575	0.00101	CcSEcCtD
Clomifene—Dyspnoea—Doxorubicin—thyroid cancer	0.000571	0.000999	CcSEcCtD
Clomifene—CYP2A6—NRF2 pathway—RXRA—thyroid cancer	0.000569	0.00297	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—CHST14—thyroid cancer	0.000556	0.0029	CbGpPWpGaD
Clomifene—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—thyroid cancer	0.000556	0.0029	CbGpPWpGaD
Clomifene—CYP2A6—Fluoropyrimidine Activity—TP53—thyroid cancer	0.000553	0.00288	CbGpPWpGaD
Clomifene—Fatigue—Doxorubicin—thyroid cancer	0.000552	0.000966	CcSEcCtD
Clomifene—CYP1A2—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000551	0.00287	CbGpPWpGaD
Clomifene—Urticaria—Epirubicin—thyroid cancer	0.00055	0.000962	CcSEcCtD
Clomifene—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000548	0.00286	CbGpPWpGaD
Clomifene—Pain—Doxorubicin—thyroid cancer	0.000548	0.000958	CcSEcCtD
Clomifene—Constipation—Doxorubicin—thyroid cancer	0.000548	0.000958	CcSEcCtD
Clomifene—Body temperature increased—Epirubicin—thyroid cancer	0.000547	0.000957	CcSEcCtD
Clomifene—ESR1—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	0.000537	0.0028	CbGpPWpGaD
Clomifene—ESR1—Signaling by ERBB4—NRG1—thyroid cancer	0.000536	0.0028	CbGpPWpGaD
Clomifene—CYP1A1—PPARA activates gene expression—RXRA—thyroid cancer	0.000532	0.00277	CbGpPWpGaD
Clomifene—EBP—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	0.000531	0.00277	CbGpPWpGaD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	0.000531	0.00277	CbGpPWpGaD
Clomifene—ESR1—Regulation of Telomerase—CCND1—thyroid cancer	0.00053	0.00276	CbGpPWpGaD
Clomifene—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—RXRA—thyroid cancer	0.000521	0.00271	CbGpPWpGaD
Clomifene—ESR1—AP-1 transcription factor network—CCND1—thyroid cancer	0.000517	0.0027	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.000517	0.00269	CbGpPWpGaD
Clomifene—Hypersensitivity—Epirubicin—thyroid cancer	0.00051	0.000892	CcSEcCtD
Clomifene—Urticaria—Doxorubicin—thyroid cancer	0.000509	0.00089	CcSEcCtD
Clomifene—Body temperature increased—Doxorubicin—thyroid cancer	0.000506	0.000886	CcSEcCtD
Clomifene—ESR1—LKB1 signaling events—TP53—thyroid cancer	0.000503	0.00262	CbGpPWpGaD
Clomifene—ESR1—Plasma membrane estrogen receptor signaling—HRAS—thyroid cancer	0.0005	0.00261	CbGpPWpGaD
Clomifene—ESR1—AP-1 transcription factor network—PTEN—thyroid cancer	0.000499	0.0026	CbGpPWpGaD
Clomifene—CYP2A6—Biological oxidations—RXRA—thyroid cancer	0.000499	0.0026	CbGpPWpGaD
Clomifene—Asthenia—Epirubicin—thyroid cancer	0.000497	0.000869	CcSEcCtD
Clomifene—CYP1A1—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000497	0.00259	CbGpPWpGaD
Clomifene—ABCB1—HIF-1-alpha transcription factor network—TERT—thyroid cancer	0.000497	0.00259	CbGpPWpGaD
Clomifene—CYP2A6—NRF2 pathway—NRG1—thyroid cancer	0.000492	0.00257	CbGpPWpGaD
Clomifene—Pruritus—Epirubicin—thyroid cancer	0.00049	0.000857	CcSEcCtD
Clomifene—ESR1—Leptin signaling pathway—CCND1—thyroid cancer	0.00049	0.00255	CbGpPWpGaD
Clomifene—ABCB1—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	0.000475	0.00248	CbGpPWpGaD
Clomifene—Diarrhoea—Epirubicin—thyroid cancer	0.000474	0.000828	CcSEcCtD
Clomifene—Hypersensitivity—Doxorubicin—thyroid cancer	0.000472	0.000825	CcSEcCtD
Clomifene—CYP19A1—Metabolism—MINPP1—thyroid cancer	0.000461	0.0024	CbGpPWpGaD
Clomifene—Asthenia—Doxorubicin—thyroid cancer	0.00046	0.000804	CcSEcCtD
Clomifene—Dizziness—Epirubicin—thyroid cancer	0.000458	0.000801	CcSEcCtD
Clomifene—ESR1—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	0.000456	0.00238	CbGpPWpGaD
Clomifene—Pruritus—Doxorubicin—thyroid cancer	0.000453	0.000793	CcSEcCtD
Clomifene—CYP11A1—Metabolism—HPGD—thyroid cancer	0.000448	0.00234	CbGpPWpGaD
Clomifene—CYP1A2—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000447	0.00233	CbGpPWpGaD
Clomifene—EBP—Metabolism—SLC5A5—thyroid cancer	0.000446	0.00232	CbGpPWpGaD
Clomifene—ESR1—Plasma membrane estrogen receptor signaling—AKT1—thyroid cancer	0.000442	0.0023	CbGpPWpGaD
Clomifene—Vomiting—Epirubicin—thyroid cancer	0.00044	0.00077	CcSEcCtD
Clomifene—Diarrhoea—Doxorubicin—thyroid cancer	0.000438	0.000767	CcSEcCtD
Clomifene—Rash—Epirubicin—thyroid cancer	0.000437	0.000763	CcSEcCtD
Clomifene—Dermatitis—Epirubicin—thyroid cancer	0.000436	0.000763	CcSEcCtD
Clomifene—Headache—Epirubicin—thyroid cancer	0.000434	0.000758	CcSEcCtD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—BRAF—thyroid cancer	0.000428	0.00223	CbGpPWpGaD
Clomifene—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000425	0.00222	CbGpPWpGaD
Clomifene—Dizziness—Doxorubicin—thyroid cancer	0.000424	0.000741	CcSEcCtD
Clomifene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000423	0.0022	CbGpPWpGaD
Clomifene—EBP—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	0.000418	0.00218	CbGpPWpGaD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	0.000413	0.00215	CbGpPWpGaD
Clomifene—Nausea—Epirubicin—thyroid cancer	0.000411	0.000719	CcSEcCtD
Clomifene—Vomiting—Doxorubicin—thyroid cancer	0.000407	0.000712	CcSEcCtD
Clomifene—Rash—Doxorubicin—thyroid cancer	0.000404	0.000706	CcSEcCtD
Clomifene—Dermatitis—Doxorubicin—thyroid cancer	0.000404	0.000706	CcSEcCtD
Clomifene—ESR1—Gene Expression—TRIM33—thyroid cancer	0.000402	0.0021	CbGpPWpGaD
Clomifene—Headache—Doxorubicin—thyroid cancer	0.000401	0.000702	CcSEcCtD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000396	0.00206	CbGpPWpGaD
Clomifene—CYP2E1—Biological oxidations—RXRA—thyroid cancer	0.000395	0.00206	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—NDUFA13—thyroid cancer	0.000392	0.00204	CbGpPWpGaD
Clomifene—CYP11A1—Corticotropin-releasing hormone—AKT1—thyroid cancer	0.00039	0.00203	CbGpPWpGaD
Clomifene—ESR1—Generic Transcription Pathway—MEN1—thyroid cancer	0.000384	0.002	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—BRAF—thyroid cancer	0.000383	0.002	CbGpPWpGaD
Clomifene—Nausea—Doxorubicin—thyroid cancer	0.000381	0.000665	CcSEcCtD
Clomifene—EBP—Metabolism—RXRA—thyroid cancer	0.000374	0.00195	CbGpPWpGaD
Clomifene—CYP1A1—Biological oxidations—RXRA—thyroid cancer	0.000372	0.00194	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—CHST14—thyroid cancer	0.000369	0.00192	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—MINPP1—thyroid cancer	0.000367	0.00191	CbGpPWpGaD
Clomifene—EBP—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	0.000364	0.0019	CbGpPWpGaD
Clomifene—KCNH2—Neuronal System—BRAF—thyroid cancer	0.000364	0.0019	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000364	0.0019	CbGpPWpGaD
Clomifene—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—thyroid cancer	0.000359	0.00187	CbGpPWpGaD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	0.000355	0.00185	CbGpPWpGaD
Clomifene—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000345	0.0018	CbGpPWpGaD
Clomifene—ESR1—AP-1 transcription factor network—TP53—thyroid cancer	0.000341	0.00178	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	0.000338	0.00176	CbGpPWpGaD
Clomifene—CYP1A1—PPARA activates gene expression—PPARG—thyroid cancer	0.000336	0.00175	CbGpPWpGaD
Clomifene—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—thyroid cancer	0.000329	0.00171	CbGpPWpGaD
Clomifene—CYP1A2—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000317	0.00165	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—CCND1—thyroid cancer	0.000313	0.00163	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—NDUFA13—thyroid cancer	0.000312	0.00163	CbGpPWpGaD
Clomifene—ESR1—Leptin signaling pathway—HRAS—thyroid cancer	0.000309	0.00161	CbGpPWpGaD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	0.000302	0.00158	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—PTEN—thyroid cancer	0.000302	0.00157	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—HPGD—thyroid cancer	0.000297	0.00155	CbGpPWpGaD
Clomifene—ESR1—Regulation of Telomerase—AKT1—thyroid cancer	0.000295	0.00154	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—CHST14—thyroid cancer	0.000293	0.00153	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—THRB—thyroid cancer	0.000291	0.00152	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—MINPP1—thyroid cancer	0.00029	0.00151	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—CCND1—thyroid cancer	0.00028	0.00146	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CALCB—thyroid cancer	0.000276	0.00144	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—MINPP1—thyroid cancer	0.000273	0.00143	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.000273	0.00142	CbGpPWpGaD
Clomifene—ESR1—Leptin signaling pathway—AKT1—thyroid cancer	0.000272	0.00142	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—PTEN—thyroid cancer	0.00027	0.00141	CbGpPWpGaD
Clomifene—ESR1—Signaling by ERBB4—PTEN—thyroid cancer	0.000269	0.0014	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	0.000263	0.00137	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—TRIM33—thyroid cancer	0.000262	0.00136	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—TPR—thyroid cancer	0.000258	0.00134	CbGpPWpGaD
Clomifene—ESR1—Generic Transcription Pathway—RXRA—thyroid cancer	0.000257	0.00134	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	0.000257	0.00134	CbGpPWpGaD
Clomifene—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—thyroid cancer	0.000256	0.00134	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—PRKAR1A—thyroid cancer	0.000253	0.00132	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000252	0.00131	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—NDUFA13—thyroid cancer	0.000247	0.00129	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000241	0.00126	CbGpPWpGaD
Clomifene—ESR1—Signaling by ERBB4—NRAS—thyroid cancer	0.00024	0.00125	CbGpPWpGaD
Clomifene—CYP1A2—Biological oxidations—RXRA—thyroid cancer	0.000237	0.00124	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—HPGD—thyroid cancer	0.000236	0.00123	CbGpPWpGaD
Clomifene—EBP—Metabolism—PPARG—thyroid cancer	0.000236	0.00123	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—NDUFA13—thyroid cancer	0.000232	0.00121	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	0.000232	0.00121	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—CHST14—thyroid cancer	0.000232	0.00121	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—KRAS—thyroid cancer	0.000232	0.00121	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	0.00023	0.0012	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	0.000227	0.00118	CbGpPWpGaD
Clomifene—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—thyroid cancer	0.000227	0.00118	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	0.000224	0.00117	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—CHST14—thyroid cancer	0.000219	0.00114	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—MINPP1—thyroid cancer	0.000218	0.00114	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—KRAS—thyroid cancer	0.000207	0.00108	CbGpPWpGaD
Clomifene—ESR1—Signaling by ERBB4—KRAS—thyroid cancer	0.000206	0.00108	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—TP53—thyroid cancer	0.000206	0.00107	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—TPR—thyroid cancer	0.000196	0.00102	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—SLC5A5—thyroid cancer	0.000193	0.00101	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	0.000193	0.001	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—HPGD—thyroid cancer	0.000187	0.000974	CbGpPWpGaD
Clomifene—EBP—Metabolism—PTGS2—thyroid cancer	0.000186	0.00097	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—NDUFA13—thyroid cancer	0.000186	0.000968	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—MEN1—thyroid cancer	0.000185	0.000963	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—TP53—thyroid cancer	0.000184	0.000961	CbGpPWpGaD
Clomifene—CYP3A4—Biological oxidations—RXRA—thyroid cancer	0.000183	0.000955	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	0.000181	0.000942	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—HPGD—thyroid cancer	0.000176	0.000918	CbGpPWpGaD
Clomifene—ESR1—Signaling by ERBB4—HRAS—thyroid cancer	0.000175	0.000914	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—CHST14—thyroid cancer	0.000175	0.00091	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—TCF7L1—thyroid cancer	0.000174	0.00091	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—MINPP1—thyroid cancer	0.000174	0.000909	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—AKT1—thyroid cancer	0.000174	0.000906	CbGpPWpGaD
Clomifene—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	0.000173	0.0009	CbGpPWpGaD
Clomifene—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000173	0.0009	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	0.000172	0.000896	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—TPR—thyroid cancer	0.000171	0.000889	CbGpPWpGaD
Clomifene—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.00017	0.000885	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—PRKAR1A—thyroid cancer	0.000168	0.000875	CbGpPWpGaD
Clomifene—KCNH2—Neuronal System—HRAS—thyroid cancer	0.000167	0.000873	CbGpPWpGaD
Clomifene—EBP—Metabolism—PTEN—thyroid cancer	0.000162	0.000846	CbGpPWpGaD
Clomifene—ESR1—Generic Transcription Pathway—PPARG—thyroid cancer	0.000162	0.000845	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—RXRA—thyroid cancer	0.000162	0.000845	CbGpPWpGaD
Clomifene—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	0.00016	0.000832	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	0.000158	0.000821	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—AKT1—thyroid cancer	0.000156	0.000811	CbGpPWpGaD
Clomifene—ESR1—Signaling by ERBB4—AKT1—thyroid cancer	0.000155	0.000807	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	0.000153	0.000796	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	0.000152	0.000793	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—NDUFA13—thyroid cancer	0.000148	0.000773	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000143	0.000745	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—HPGD—thyroid cancer	0.000141	0.000734	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—CHST14—thyroid cancer	0.000139	0.000726	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—TPR—thyroid cancer	0.000136	0.000708	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	0.000136	0.000708	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—MINPP1—thyroid cancer	0.000135	0.000701	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—PRKAR1A—thyroid cancer	0.000134	0.000697	CbGpPWpGaD
Clomifene—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000129	0.000673	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	0.000129	0.000672	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—SLC5A5—thyroid cancer	0.000128	0.000666	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—TSHR—thyroid cancer	0.000128	0.000666	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—PRKAR1A—thyroid cancer	0.000126	0.000655	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—RXRA—thyroid cancer	0.000124	0.000644	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	0.000123	0.000639	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—MEN1—thyroid cancer	0.00012	0.000626	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	0.00012	0.000624	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	0.000118	0.000617	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—NDUFA13—thyroid cancer	0.000114	0.000596	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—HPGD—thyroid cancer	0.000112	0.000586	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—PTCH1—thyroid cancer	0.000109	0.000566	CbGpPWpGaD
Clomifene—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000109	0.000566	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—CHST14—thyroid cancer	0.000108	0.000561	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—TPR—thyroid cancer	0.000107	0.000559	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—RXRA—thyroid cancer	0.000107	0.000559	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—PRKAR1A—thyroid cancer	0.000106	0.00055	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	0.000104	0.000544	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—PPARG—thyroid cancer	0.000102	0.000533	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—SLC5A5—thyroid cancer	0.000102	0.00053	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—TPR—thyroid cancer	0.000101	0.000527	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—PRKAR1A—thyroid cancer	9.95e-05	0.000519	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—SST—thyroid cancer	9.93e-05	0.000518	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CALCA—thyroid cancer	9.56e-05	0.000498	CbGpPWpGaD
Clomifene—EBP—Metabolism—AKT1—thyroid cancer	9.35e-05	0.000487	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	9.11e-05	0.000475	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	9.09e-05	0.000474	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	9.02e-05	0.00047	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—HPGD—thyroid cancer	8.67e-05	0.000452	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CDK1—thyroid cancer	8.65e-05	0.000451	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—RXRA—thyroid cancer	8.54e-05	0.000445	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—TPR—thyroid cancer	8.08e-05	0.000421	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	8.08e-05	0.000421	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—PTGS2—thyroid cancer	8.05e-05	0.000419	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—SLC5A5—thyroid cancer	8.03e-05	0.000419	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—PRKAR1A—thyroid cancer	7.95e-05	0.000414	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—PPARG—thyroid cancer	7.8e-05	0.000407	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—SLC5A5—thyroid cancer	7.57e-05	0.000395	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	7.1e-05	0.00037	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—PTEN—thyroid cancer	7.02e-05	0.000366	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—NRG1—thyroid cancer	6.95e-05	0.000362	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	6.82e-05	0.000356	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—PPARG—thyroid cancer	6.78e-05	0.000353	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—RXRA—thyroid cancer	6.75e-05	0.000352	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—TPR—thyroid cancer	6.45e-05	0.000336	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—RXRA—thyroid cancer	6.36e-05	0.000332	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	6.35e-05	0.000331	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—TERT—thyroid cancer	6.24e-05	0.000325	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	6.19e-05	0.000323	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—SLC5A5—thyroid cancer	6.05e-05	0.000315	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—HIF1A—thyroid cancer	5.96e-05	0.000311	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	5.75e-05	0.0003	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—PPARG—thyroid cancer	5.39e-05	0.000281	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—PTGS2—thyroid cancer	5.33e-05	0.000278	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—RXRA—thyroid cancer	5.08e-05	0.000265	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—TPR—thyroid cancer	4.98e-05	0.00026	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—BRAF—thyroid cancer	4.94e-05	0.000258	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	4.9e-05	0.000255	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—SLC5A5—thyroid cancer	4.83e-05	0.000252	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—PTEN—thyroid cancer	4.65e-05	0.000242	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	4.53e-05	0.000236	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—PPARG—thyroid cancer	4.26e-05	0.000222	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—PTGS2—thyroid cancer	4.24e-05	0.000221	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—RXRA—thyroid cancer	4.06e-05	0.000212	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—AKT1—thyroid cancer	4.04e-05	0.000211	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—PPARG—thyroid cancer	4.02e-05	0.000209	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.95e-05	0.000206	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—SLC5A5—thyroid cancer	3.73e-05	0.000194	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—PTEN—thyroid cancer	3.7e-05	0.000193	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CCND1—thyroid cancer	3.6e-05	0.000188	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—PTEN—thyroid cancer	3.48e-05	0.000181	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—PTGS2—thyroid cancer	3.35e-05	0.000175	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—PPARG—thyroid cancer	3.21e-05	0.000167	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—PTGS2—thyroid cancer	3.16e-05	0.000165	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—RXRA—thyroid cancer	3.13e-05	0.000163	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—NRAS—thyroid cancer	3.1e-05	0.000162	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—AKT1—thyroid cancer	3.08e-05	0.000161	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—PTEN—thyroid cancer	2.92e-05	0.000152	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—PTEN—thyroid cancer	2.76e-05	0.000144	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—AKT1—thyroid cancer	2.68e-05	0.00014	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—KRAS—thyroid cancer	2.67e-05	0.000139	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—PPARG—thyroid cancer	2.56e-05	0.000134	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—PTGS2—thyroid cancer	2.52e-05	0.000132	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—TP53—thyroid cancer	2.37e-05	0.000124	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—HRAS—thyroid cancer	2.27e-05	0.000118	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—PTEN—thyroid cancer	2.2e-05	0.000115	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—AKT1—thyroid cancer	2.13e-05	0.000111	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—PTGS2—thyroid cancer	2.02e-05	0.000105	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—AKT1—thyroid cancer	2.01e-05	0.000105	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PPARG—thyroid cancer	1.98e-05	0.000103	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—PTEN—thyroid cancer	1.76e-05	9.16e-05	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—AKT1—thyroid cancer	1.68e-05	8.78e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—AKT1—thyroid cancer	1.59e-05	8.28e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PTGS2—thyroid cancer	1.56e-05	8.11e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PTEN—thyroid cancer	1.36e-05	7.07e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—AKT1—thyroid cancer	1.27e-05	6.61e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—AKT1—thyroid cancer	1.01e-05	5.28e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—AKT1—thyroid cancer	7.82e-06	4.08e-05	CbGpPWpGaD
